Active13804492Private limited companyLondon

ENTOS PHARMACEUTICALS U.K. LTD

Significant control: John David Lewis (50–75%)

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Entos Pharmaceuticals U.K. Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Entos Pharmaceuticals U.K. Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

ENTOS PHARMACEUTICALS U.K. LTD is an active private limited company (company number 13804492) incorporated on 16 December 2021, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.

There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.

Ownership and control

1 active

JD
John David Lewis
Individual · since 16 December 2021
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
50–75%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 16 December 20214 yrs ago
First accounts due: 16 September 20231137 days overdue
Confirmation statement due: 30 December 2026in 64 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Total Exemption Full

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated two to five years agoIncorporated 16 December 2021
Accounts past their due dateDue 16 September 2023

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

30 Dec 2026Confirmation statement duein 64 days
16 Sept 2023First accounts due1137 days overdue
16 Dec 2021Incorporated

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 16 December 2021 · in Dec 2021.

Reminders for ENTOS PHARMACEUTICALS U.K. LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.